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Whether a pathogen entering a new host species results in a single
infection or in onward transmission, and potentially an outbreak,
depends upon the progression of infection in the index case.
Although index infections are rarely observable in nature, exper-
imental inoculations of pathogens into novel host species provide
a rich and largely unexploited data source for meta-analyses to
identify the host and pathogen determinants of variability in in-
fection outcomes. We analyzed the progressions of 514 experi-
mental cross-species inoculations of rabies virus, a widespread
zoonosis which in nature exhibits both dead-end infections and
varying levels of sustained transmission in novel hosts. Inocula-
tions originating from bats rather than carnivores, and from
warmer- to cooler-bodied species caused infections with shorter
incubation periods that were associated with diminished virus ex-
cretion. Inoculations between distantly related hosts tended to
result in shorter clinical disease periods, which are also expected
to impede onward transmission. All effects were modulated by
infection dose. Taken together, these results suggest that as host
species become more dissimilar, increased virulence might act as a
limiting factor preventing onward transmission. These results can
explain observed constraints on rabies virus host shifts, describe a
previously unrecognized role of host body temperature, and pro-
vide a potential explanation for host shifts being less likely between
genetically distant species. More generally, our study highlights
meta-analyses of experimental infections as a tractable approach
to quantify the complex interactions between virus, reservoir, and
novel host that shape the outcome of cross-species transmission.
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Cross-species transmission is an important source of emergingand endemic disease. Viruses such as West Nile virus, rabies
virus, and Lassa virus cause tens of thousands of human infec-
tions annually through transmission from animal reservoirs
(1–3). Cross-species transmission is also the first step toward host
shifts, where pathogens establish transmission cycles in novel
hosts (4). While the broader-scale epidemiological and ecologi-
cal factors driving cross-species transmission are beginning to be
understood (reviewed in refs. 5–7), we remain unable to antici-
pate whether cross-species transmission will cause “dead-end”
infections or transmit onward. Infection dynamics at the cross-
species interface, specifically the probability of infection given
exposure and the progression of index infections in novel hosts,
are generally unobservable in nature. This is a crucial gap given
that the outcomes of cross-species infections have profound
implications for host shifts and disease emergence.
Cross-infection studies, in which viruses from a natural res-
ervoir are experimentally inoculated into novel host species,
provide a rare view into the dynamics of index infections. Since
the dose, route, timing, and origin of viral exposure are known,
these factors can be controlled for to identify the biological and
evolutionary rules that govern the outcomes of cross-species trans-
mission. We focus on Rabies lyssavirus (family Rhabdoviridae) as a
model pathogen for understanding cross-species transmission (8).
Rabies virus is a primarily bite-transmitted zoonotic RNA virus that
infects all mammals and, untreated, has the highest case fatality
ratio of any viral disease (9, 10). Rabies virus naturally infects
multiple carnivore and bat species, which each perpetuate species-
specific maintenance cycles (11). Although most cross-species
transmission events do not lead to onward transmission, each
maintenance cycle represents a rare past cross-species transmis-
sion event that established transmission in a novel host. Dead-end
cross-species transmissions and historical host shifts are detectable
in rabies virus phylogenies, and epidemiological surveillance re-
veals that nascent host shifts remain commonplace (11–13). As
such, rabies virus exhibits extensive variation in the epidemiolog-
ical outcomes of cross-species transmission. Here, we exploit
cross-infection studies conducted over several decades, in which
diverse mammalian species were inoculated with rabies viruses of
bat and carnivore origin, to investigate the individual-level out-
comes of index infections.
The potential for onward transmission of rabies virus is likely
to depend on the incubation period (from bite to the appearance
of clinical signs) and the duration of clinical signs prior to death
(here, the clinical period) of infected hosts. Longer incubation
periods are associated with greater distribution of virus through
the central nervous system (14), spread to a wider range of tis-
sues (15), and higher virus titers in the salivary glands, all of
which should facilitate onward transmission (16). Conversely,
faster progression of infection has been associated with lower
virus excretion, and in extreme cases animals die before the virus
reaches the salivary glands, making transmission highly unlikely
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(14–17). Further, the clinical period of rabies coincides with the
period of greatest infectivity, when excretion of virus in the saliva
often coincides with clinical signs such as aggression which
promote transmission (18). Testing for shifts in incubation and
clinical period durations, and in the amount of virus excreted,
allows us to examine what plausible factors may constrain on-
ward transmission of rabies in index hosts following cross-species
transmission.
Based on previous work on rabies virus and in other host–
pathogen systems, several mechanisms are hypothesized to in-
fluence infection dynamics and the outcome of cross-species
transmission (Fig. 1):
1) Features of exposed host species (host effects), irrespective
of the infecting virus. For example, larger-bodied species may
be more resistant to infection and thus require either higher
infectious doses or a longer period of virus replication before
symptoms become apparent. More generally, evolutionarily
conserved similarities in host physiology mean that groups of
related taxa might have similar susceptibility or clinical out-
comes of infection (19).
2) Features inherent to the virus lineage involved (virus effects),
irrespective of the infected host, likely due to adaptation of
individual lineages to reservoir host species. Although rabies
virus has shifted multiple times within and between bats and
carnivores, only a handful of amino acid changes have been
linked to host adaptation (12, 20, 21). Relatively little is
known about how these amino acid changes contribute to
infection phenotypes (21). Further, key differences in disease
presentation between rabies viruses adapted to bats and
those adapted to carnivores have been noted in humans, al-
though it remains unclear whether this is a feature of the
virus or due to differing routes of exposure (22).
3) Host–virus interactions. Both initial cross-species transmission
and successful establishment occur most often between closely
related hosts, often referred to as the phylogenetic distance
effect (13, 19, 23, 24). However, the mechanisms underlying
this pattern remain obscure. Mammals also exhibit consider-
able variability in physiological features that are only moder-
ately constrained by phylogenetic relatedness, such as body
temperature (25). This may create distantly related pairs of
reservoir and novel host species which nevertheless share key
physiological features affecting disease outcome (26), a poten-
tial explanation for the occurrence of host shifts over wide
phylogenetic scales.
Here, we test these hypotheses by conducting a meta-analysis
of individual-level data from 514 published experimental cross-
species infections involving rabies virus. We show that features of
the virus and of the inoculated host species interact with the
initial conditions of exposure to influence the outcome of cross-
species transmission in ways expected to affect the likelihood of
onward transmission in the novel host species.
Results
Our meta-analysis of cross-species inoculation experiments
recorded results from 65 experiments in total. In agreement with
observations from natural infections (27, 28), not all inoculations
resulted in clinical rabies. Only 1,054 (63%) of the 1,672 inoc-
ulated animals for which any data were available developed ra-
bies during the observation periods of the included experiments.
The proportion of animals which developed rabies was similar
among both within-species (525/822) and cross-species inocula-
tions (529/850).
All analyses below were performed on data from cross-species
inoculations only. A total of 30 experiments provided cross-species
inoculation data for at least one of the three outcome measures of
interest: the duration of the incubation period (n = 443 inocula-
tions) and clinical period (n = 178) and the amount of virus ex-
creted (n = 278). These experiments involved 20 mammal species
(in the orders Carnivora, Chiroptera, Cetartiodactyla, and Roden-
tia), inoculated with 39 unique inocula from seven reservoir species
in the orders Carnivora and Chiroptera (Fig. 1 and Table 1). The
experiments analyzed were published in 23 publications between
1958 and 2013.
Incubation Period. The time period between inoculation and the
appearance of symptoms was highly variable, with a median
duration of 15 d. While incubation periods ranged between 4 and
141 d, 95% lasted ≤28 d (all estimates based on a nonparametric
Kaplan–Meier fit to the censored event times).
We modeled incubation period duration using log-normal
generalized linear mixed models (GLMMs), correcting for phy-
logenetic nonindependence among inoculated species and among
BA
Fig. 1. Experimental setup and data analyzed in this study. (A) Data were collected from published experiments in which naturally circulating rabies virus
isolates were inoculated into heterologous species. The delay between inoculation and the appearance of clinical signs (the incubation period) and the delay
between clinical signs first appearing and death (the clinical period) was recorded for individual animals. (B) Species combinations for which data were
available. Colored lines connect observed reservoir-inoculated species pairs, with line thickness indicating the number of inoculations providing data on at
least one of the variables analyzed (incubation period, clinical period, or salivary gland virus titer). Three reservoir species (Canis aureus, Tadarida brasiliensis,
and Desmodus rotundus) received no inoculations which met our inclusion criteria.
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reservoir species, as well as for clustering within experiments
(Methods). As expected, incubation periods were shortened by
both increased dose (Fig. 2A) and potentially also by inoculation
sites which were relatively closer to the brain (95% highest pos-
terior density interval [HPD]: −0.024 to 0.704; Fig. 2A). More
importantly, the duration of incubation periods was also influ-
enced by features of the virus reservoir as well as its interaction
with the inoculated host. Specifically, differences in incubation
period duration were associated with reservoir type (bat vs. car-
nivore) and with body temperature differences between source
and inoculated hosts (Fig. 2A). Both effects depended on viral
dose (HPD: 0.113 to 0.752 and 0.346 to 1.045, respectively;
Fig. 2A). At low doses, viruses from bat reservoirs were associated
with shorter incubation periods compared to viruses from carni-
vores, though this effect diminished at higher doses (Fig. 2B).
There was some evidence that inoculated species which are known
to be capable of acting as rabies reservoirs in nature experienced
shorter incubation periods than other species at low doses
(HPD: −0.002 to 0.864; Fig. 2A).
The difference in typical body temperature between the virus
reservoir and the inoculated species had a more marked effect
on incubation periods (Fig. 2A). The onset of symptoms was
delayed when the virus was inoculated into species with a warmer
body temperature than its reservoir (negative values in Fig. 2D),
although this delay reduced with higher doses. The opposite was
also true—hosts with lower body temperatures than the virus
reservoir tended to have shorter incubation periods (Fig. 2D and
SI Appendix, Fig. S1). Models fitting effects for inoculated and
reservoir species body temperature separately allowed us to ex-
plore this temperature effect further. Regardless of viral origin,
inoculated species with higher typical body temperatures tended
to have longer incubation periods (interacting with dose, HPD:
−1.013 to −0.071; SI Appendix, Fig. S2). However, viruses from
reservoirs with higher body temperatures were associated with
shorter incubation periods across all inoculated hosts (again
interacting with dose, HPD: 0.117 to 0.588), suggesting that these
viruses had adapted to counteract any losses in efficiency caused
Table 1. Number of observations and hierarchical structure of
data available from experimental cross-species inoculations
involving rabies virus
Incubation
period
Clinical
period
Virus titer in
salivary glands
Individual inoculations
(sample size)
443 178 278
Publications 19 15 16
Experiments 25 20 20
Inocula 35 18 22
Source taxonomic
orders/species
2/7 2/4 2/4
Inoculated taxonomic
orders/species
4/19 4/13 4/18
Source-inoculated
species combinations
30 20 25
Inocula refers to the different virus isolates used; publications might contain
multiple discrete experiments conducted by the same research group.
A
D E
B
C
Fig. 2. Factors affecting the progression of disease following cross-species inoculations. (A) Coefficient estimates from independent models fit to the du-
ration of incubation (n = 443 inoculations) and clinical periods (n = 178 inoculations). In addition to the variables shown, both models contained corrections
for nonindependence between observations from the same experiment and for inoculated species phylogeny. The regression on incubation period durations
additionally contained corrections for reservoir phylogeny. Lines indicate the extent of the 95% HPD, while points indicate the posterior median. Shaded
areas show the posterior distribution, with color used to indicate estimates whose 95% HPD excludes zero. (B–E) Predicted incubation period and clinical
period durations when varying dose along with (B) reservoir taxonomic order, (C) whether or not the inoculated species was a known reservoir of rabies virus,
(D) the difference in typical body temperatures between the virus reservoir and the inoculated species (specifically reservoir temperature minus inoculated
species temperature), or (E) phylogenetic distance between species. For each set of predictions, all other explanatory variables in the model were held
constant at their median observed value. In B and C, each subpanel shows the predicted effect at different quantiles, Q, of observed doses (in log10 mouse
LD50), indicated above the panel. In D and E, panels are zoomed into the area containing 90% of observed values on each axis, and colors show the posterior
median of predictions. Black lines along the edges of D and E indicate the locations of observed values for the variable on each axis.
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by the body temperature of their reservoir host. Many bat species
have lower body temperatures than most carnivore species, but
the distributions of body temperatures across bats and carnivores
show considerable overlap (SI Appendix, Fig. S3). Importantly,
there was little correlation between phylogenetic distance and
body temperature difference among species (SI Appendix, Fig.
S3), indicating that the observed temperature effects were not
explainable by the level of taxonomic relatedness among species.
All fixed effects combined explained 19.2% of the variation in
incubation period durations (HPD: 2.8 to 40.2%).
Clinical Period. Once symptoms appeared, the median time to
death (the clinical period) was 2 d, ranging from <1 d to 8 d. We
modeled clinical period duration using log-normal GLMMs,
correcting for phylogenetic clustering among inoculated species
and for clustering within experiments. As observed for incuba-
tion periods, increasing relative distance between the inoculation
site and the brain increased clinical period durations (HPD:
0.131 to 1.221), while dose interacted with a range of other
factors (Fig. 2A). Cross-species inoculations between phyloge-
netically more distant species were associated with an increased
sensitivity to high viral doses, resulting in shorter clinical periods
(HPD: −1.966 to −0.363; Fig. 2 A and E). Bat-associated viruses
appeared to have shorter clinical periods, and—as also observed
for incubation periods—this effect depended on dose, but here it
was poorly estimated (HPD: −0.144 to 2.913; Fig. 2A). Similarly,
the clinical period durations of species which are known reser-
voirs responded more strongly to increasing doses than those of
other species, which might be indicative of more efficient viral
replication and/or cell-to-cell spread in these species (HPD:
−2.958 to −0.554; Fig. 2 A and C). Combined, the fixed effects
explained 43.7% of the variation in clinical period duration
(HPD: 15.7 to 62.7%).
Virus Titer in Salivary Glands. Onward transmission of rabies virus,
which is mediated by an animal bite, requires presence of the
virus in sufficiently high titers in the salivary glands. To test how
the host–virus context of cross-species transmission affects the
amount of virus excreted, we investigated the virus titer detected
in salivary glands postmortem as a proxy. To simultaneously in-
vestigate potential explanations for the previously reported
correlation between salivary gland virus titer and incubation
period duration (14–16), we modeled the virus titer excreted
jointly with incubation periods using a multiresponse log-normal
GLMM. When accounting only for clustering within experi-
ments, salivary gland titers showed a moderate positive correla-
tion with incubation period duration (Pearson correlation: 0.298,
HPD: 0.115 to 0.471; Fig. 3A). Thus, consistent with previous
work, animals which experienced longer incubation periods
tended to have more virus in their salivary glands postmortem.
Part of this correlation is accounted for by the inoculated species
phylogeny, with related species having similar incubation periods
and excreting similar amounts of virus (Fig. 3B). The remaining
residual correlation is explained by differences in dose (Fig. 3C),
with higher doses leading to decreased salivary gland titers
(Fig. 3D). We did not find convincing evidence for a similar
correlation between clinical period durations and salivary gland
titers (Pearson correlation: −0.123, HPD: −0.411 to 0.172 once
correlation within experiments was accounted for), but this was
based on limited data (n = 80). The dose-dependent body tem-
perature difference effect observed for incubation periods was
poorly estimated in the salivary gland titer model, with a large
posterior median effect size (−2.445) but high levels of uncer-
tainty (HPD: −5.896 to 0.961; Fig. 3 D and E). A somewhat
clearer effect was observed for the interaction of reservoir status
and dose: At low doses, known rabies reservoir species produced
higher virus titers in the salivary glands than nonreservoirs
(HPD: −5.698 to −0.164; Fig. 3 G and F). At very high doses,
however, we detected no difference in salivary gland titers, pos-
sibly because animals succumb too fast for any differences to
develop (Fig. 3F).
Discussion
The progression of viral infections within the index host fol-
lowing cross-species transmission is a crucial determinant of
onward transmission but is generally unobservable in nature. By
analyzing a unique dataset of experimental cross-species infec-
tions, we demonstrate that phylogenetic distance and specific
physiological differences between the host species involved alter
the progression of infections in ways that are expected to influ-
ence whether further transmission occurs in the novel host.
The association between incubation period duration and the
amount of virus detected in the salivary glands suggests a direct
mechanism linking longer incubation periods to onward trans-
mission. Species with higher body temperatures than the reser-
voir host tended to have longer incubation periods, specifically at
lower viral inoculation doses (Fig. 2D). Although one might
expect body temperature to be a phylogenetically conserved trait,
we found little correlation with phylogenetic distance (SI Ap-
pendix, Fig. S3A), and others have shown that body temperatures
are clustered primarily at higher taxonomic levels (25). The
finding that incubation period duration is influenced by body
temperature is consistent with in vitro experiments showing that
temperature can affect the infectivity of rabies virus, possibly by
altering the rate of cell-to-cell spread (29). Further, exposing
rabies-inoculated mice to high ambient temperatures has been
shown to delay the onset of symptoms (30). However, the spe-
cific mechanisms that could shorten incubation periods in a
novel host environment which is colder than the host environ-
ment to which the virus is adapted as observed here remain to be
identified, and we cannot exclude the possibility that body tem-
perature differences are a proxy for other physiological differ-
ences between species.
Crucially, we found clear evidence for virus adaptation to a
specific host environment (SI Appendix, Fig. S2), consistent with
infection progression being matched to each host species. Given
this host adaptation and poor correspondence between body
temperature differences and phylogenetic distance, the observed
temperature effect may help explain rabies virus host shifts
across large phylogenetic distances. For example, despite host
shifts from bats into carnivores being generally very rare, rabies
virus has shifted repeatedly from big brown bats (Eptesicus fus-
cus, 36 °C) to striped skunks [Mephitis mephitis, 36.45 °C (12,
31)]. More generally, our results suggest that transmissions to
species with warmer typical body temperatures than the current
reservoir are more likely to become established, since this would
be expected to result in longer incubation periods and higher
virus excretion. This might explain observations suggesting sus-
tained transmission of rabies virus lineages associated with
common vampire bats (Desmodus rotundus, 35 °C) in sympatric
frugivorous bats [Artibeus lituratus, 37.3 °C (31–33)].
The observation that low doses of viruses from bat reservoirs
resulted in shorter incubation periods relative to those from car-
nivores (Fig. 2 A and B) suggests increased infectivity and/or faster
within-host spread among bat-adapted rabies viruses. Since our
data were limited to viruses from two bat reservoirs—with 82% of
these associated with one species, Tadarida brasiliensis (Fig. 1)—it
remains unclear whether this is a general feature of bat-associated
rabies viruses. However, similar results have been observed in
humans, where both incubation and clinical periods were shorter
when the virus originated from bats rather than carnivores (22).
This bat-associated effect may be the result of body temperature
differences—at 35 and 36 °C, the two bat reservoirs included had
cooler body temperatures than almost all inoculated species (SI
Appendix, Fig. S3). Alternatively, since bats are considerably
smaller than known carnivore reservoirs and likely transfer much
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smaller volumes of saliva during transmission, bat-associated
rabies viruses may be adapted to transmit at lower doses. Al-
though it may be expected that smaller animals would succumb
faster to a given dose, we found no evidence that the interaction
between the body mass of inoculated species and dose affects the
duration of incubation or clinical periods (Fig. 2A).
Following the incubation period, the appearance of clinical
signs of disease typically coincides with viral excretion and
transmission. The duration of clinical signs is therefore crucial in
determining whether an index host can transmit to conspecifics.
Notably in the case of rabies virus, the clinical period coincides
with the onset of signs such as aggression that facilitate onward
spread through biting. It is also relatively short and invariably
ends in death of the infected host, terminating transmission op-
portunities (18). Increased phylogenetic distances between virus
reservoirs and inoculated species appear to reduce the duration of
clinical periods (Fig. 2E). Such increased virulence would mean
that onward transmission becomes increasingly unlikely following
cross-species infection between more distant relatives. This is
consistent with previous work showing that the number of
successful rabies virus host shifts among North American bats
decreases with phylogenetic distance (13).
Because rabies virus is generally transmitted via bite, the amount
of virus excreted in the salivary glands will affect the probability of
transmission from the index case. Further, the overall strong effects
of dose we observed suggest that the amount of virus transferred to
secondary cases will be a primary determinant of disease progres-
sion in secondary cases and hence further transmission in the new
host population. Such effects on onward transmission are likely to
be nonlinear, with a potentially diminishing effect at very high
doses. However, it is notable that nonreservoirs tended to have
lower virus titers in their salivary glands than established rabies
virus reservoirs (Fig. 3 D and F), which may explain why the virus
remains restricted to a relatively small number of reservoir hosts
despite frequent spillovers to other species (11). Our results also
provide tentative evidence of shorter incubation periods in non-
reservoirs (Fig. 2A). The exact mechanisms underlying these dif-
ferences between known rabies virus reservoirs and other species
remain unexplained but are likely to be evolutionarily conserved,
D E
F
A B C
Fig. 3. Factors predicting the titer of virus in salivary glands following cross-species inoculation (all models fitted to data from 514 inoculations, of which 278
provided data on salivary gland titers, 443 provided data on incubation period duration, and 207 included data on both). (A) Correlation between virus titer
and the duration of incubation periods, after accounting for clustering within experiments. Shown is the estimated posterior distribution from a multi-
response regression fitted using the mcmcGLMM library in R, with the darker shaded area indicating the extent of the 95% HPD. (B and C) The remaining
correlation is reduced when also accounting for correlation of virus titer and incubation period duration within the inoculated species phylogeny (B) and
further reduced to ∼0 when additionally accounting for differences in inoculated dose (C). (D) Coefficient estimates for the regression on log virus titers in the
salivary glands, when accounting for clustering within experiments and the inoculated species phylogeny. Lines indicate the extent of the 95% HPD, while
points show the posterior median and shaded areas the shape of the posterior distribution, with color used to indicate estimates whose 95% HPD excludes
zero. (E and F) Predicted salivary gland titers when varying dose and either the difference in body temperatures between the virus reservoir and the in-
oculated species (E) or whether or not the inoculated species is a known rabies virus reservoir (F), while keeping all other variables in the model constant. E
shows the posterior median of predicted virus titers, with black lines along the edges indicating the locations of observed values and is zoomed to the area
covering 90% of observed values along both axes. In F, predictions are shown at different quantiles of dose (in log10 mouse LD50), as indicated above
each subpanel.
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given the phylogenetic clustering in excretion levels apparent in
our analysis.
Overall, our results point to adaptation of the rate of disease
progression to match individual host species. Studies of rabies
virus host shifts have thus far failed to find sites in the virus
genome which consistently change during host adaptation (12,
20, 34). This has led to the suggestion that host adaptation can be
achieved through numerous sets of molecular changes (34),
which would indeed be the case if the requirement is to balance
disease progression to the point where onward transmission
becomes likely. In some host–pathogen systems, such adaptation
is explained by a trade-off between selection for faster growth to
maximize viral load, and thereby infectiousness, and selection for
reduced host damage (virulence) to maximize transmission op-
portunities (35, 36). In contrast, we observed a positive correla-
tion between salivary gland titers and incubation period duration,
implying that slower host damage leads to greater infectiousness.
This, in turn, suggests a trade-off between faster replication and/or
spread (speeding up disease progression) and the ability to reach
the salivary glands via functioning neural pathways. Such a trade-
off is supported by the observation that the correlation between
incubation period duration and salivary gland virus titer was
modulated in part by dose (Fig. 3C), with higher amounts of virus
reducing both.
The experimental data analyzed here offer a unique view on
index infection dynamics following cross-species transmission. By
revealing the complex links between dose, physiological differ-
ences between hosts, disease progression, and virus excretion,
our analyses bring us closer to being able to model and predict
the process of disease emergence and host shifts. The large
dataset of controlled infections further enabled us to generate
disease progression parameter distributions for all observed
combinations of within- and cross-species transmissions which can
be directly applied in future efforts to model rabies transmission
dynamics (37). It is of note that some effects observed here were
eventually overcome by high doses (Figs. 2 B and D and 3F; the
median dose across all experiments was 12,679 mouse median
lethal doses [LD50]), and future infection studies should aim to
utilize doses closer to those of natural exposures. Following cross-
species transmission, rabies virus shows increased virulence
(i.e., more rapid death) in more distantly related species, to the
point that opportunities for transmission are likely to be markedly
reduced. At the same time, a mismatch in host physiological
features (including features not strongly correlated with phylog-
eny, such as body temperature) can alter both infectivity and
disease progression, with implications for onward transmission.
Thus, the picture that emerges is one of a potential virulence
mismatch in index infections, that may partially explain why—
despite having the ability to infect all mammals and frequent in-
volvement in cross-species transmission events—rabies virus re-
mains restricted to a relatively small number of species-specific
maintenance cycles.
While the determinants of cross-species transmission have
been the subject of intense research (reviewed in refs. 5–7), the
very next step, that is, what happens during the initial infection to
determine the likelihood of onward transmission, has remained
relatively unexplored. Our results show that meta-analyses of cross-
species infection experiments provide a tractable means of investi-
gating this process. Expanding such analyses to other viruses may
allow us to identify general rules which predict the outcome of
cross-species transmissions. More work is needed to understand the
host features that affect the probability of infection upon exposure,
the within-host mechanisms driving virulence, and the epidemio-
logical consequences of differences in disease progression and virus
excretion. Our findings illustrate how understanding these mecha-
nisms will be key to predicting which cross-species exposures are
most likely to lead to future host shifts of rabies virus, and of
zoonotic diseases more broadly.
Methods
Literature Search and Data Collection. A search for published rabies virus
infection studies was performed as described in SI Appendix, Supplementary
Information Text. Searching across the PubMed and Web of Science data-
bases yielded 2,279 records on 16 January 2015. These records were
reviewed according to the criteria listed in SI Appendix, Table S2 to select
studies for inclusion in the meta-analysis.
From each study, we recorded individual-level data on the species inoc-
ulated, the dose, inoculation route and site, and the reservoir host species of
the virus used. Response variables, when available, included the observed
incubation and clinical period durations and the titer of virus present in the
salivary glands postmortem. Incubation and clinical period data comprised a
mixture of exact times, interval-censored times (i.e., studies only reported
ranges for groups of animals), and right-censored observations (i.e., deaths
unrelated to rabies before the conclusion of the study or killing of survivors
at the end of each study). Right-censored observations were rare, however,
and the final dataset of cross-species inoculations analyzed here contained
only exact and interval-censored observations. In particular, all animals for
which clinical period durations were available had been observed until
rabies-induced death and with only one exception stem from studies pub-
lished between 1958 and 1995 (i.e., generally from before killing of animals
showing signs of disease became common practice).
Taxonomic classifications were updated to match ref. 38, by matching the
scientific and common names given in each publication against the Inte-
grated Taxonomic Information System database (https://www.itis.gov/). Data
from our meta-analysis were supplemented with species-level data from the
PanTHERIA database, along with body-temperature data from the AnAge
database (31, 39). Because not all records were resolved to subspecies level,
and external data sources only contained data at the species level, infor-
mation on the specific subspecies involved was ignored in the analyses de-
scribed here. This resulted in two pairs of subspecies being clustered together,
while two domesticated species were analyzed using species-level data for
their wild ancestor (SI Appendix, Table S1). Further data cleaning and valida-
tion steps are described in SI Appendix, Supplementary Information Text.
Accelerated Failure Time Model. The durations of incubation and clinical
periods were modeled using independent GLMMs on the censored event
times, in this context more frequently termed accelerated failure time
models. These models perform a regression on the waiting time to some
specific event (e.g., the appearance of clinical signs, signifying the end of the
incubation period), with coefficients acting to increase or decrease the time
to the event. We assumed a log-normal distribution for the event times T.
Thus, the duration of the incubation period of each individual i of species r
(the inoculated species), inoculated with a virus from species d (the source or
reservoir species) in experiment j was modeled as
f(Yi,d,r,j ⃒⃒μi,d,r,j , σe) ∼ N(μi,d,r,j , σ2e )
μi,d,r,j = X’iβ + pd + qr +md + nr + oj ,
where Y = log(T), while μi,d,r,j and σe are the mean and SD of a normal dis-
tribution, respectively. Coefficients are represented by βi, with X
’
i repre-
senting a vector of data on potential explanatory variables. Finally, (p,q) and
(m,n,o) respectively represent phylogenetic and nonphylogenetic random
effects for the source species (the virus reservoir, p andm), inoculated species
(q and n), and experiment (o).
Phylogenetic random effects were drawn from a multivariate normal
distribution taking the form
p ∼ Nk 0, σ2pAp( )
q ∼ Nl 0, σ2qAq( ),
where 0 is a vector of zeros (of length k or l, equal to the number of source
or inoculated species, respectively), and σ2p and σ
2
q are variance parameters.
Ap and Aq represent correlation matrixes for all source and inoculated spe-
cies, respectively. These matrixes were calculated from a composite time-
scaled phylogeny generated by timetree.org (40) assuming a Brownian
model of trait evolution using version 3.5 of the APE package in R (41, 42).
These random effects adjust for potential correlation in the response vari-
ables due to relatedness. Similar results were obtained when using the
mammalian supertree of ref. 43, but this supertree had a slightly lower
resolution than the timetree.org phylogeny.
The nonphylogenetic random effects took the form
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md ∼ N(0, σ2m)
nr ∼ N(0, σ2n)
oj ∼ N(0, σ2o),
where σ2m and σ
2
n, respectively, measure the variance between source and in-
oculated species not captured by the Brownian model (19), while σ2o measures
the variance between experiments. A similar model was used for the duration
of clinical periods, except that data were pooled across virus reservoirs by re-
moving the random effects for reservoir species and reservoir phylogeny (p
and m above). This was necessary because the clinical period data involved
viruses from just four reservoir species, making it impossible to accurately es-
timate the variance between observations associated with different reservoirs.
To accommodate censoring, the vector of event times, T, was treated as a
latent variable. When only the range of incubation or clinical period dura-
tions was given for a specific group of animals, data were treated as interval
censored, that is, Ti,d,r,j ∈ [Li,d,r,j ,Ui,d,r,j], where L and U represent the lower
and upper boundaries of observed event times (SI Appendix, Supplementary
Information Text). Exact observations were recorded by setting Li,d,r,j = Ui,d,r,j.
Multiresponse Models. In an independentmodel, the amount of virus detected in
salivary glands postmortemwasmodeled jointly with incubation period durations,
to allow estimation of the amount of residual correlation between incubation
period duration and the amount of virus in the salivary glands. Several authors
have noted a link between these measures (14–16), but it remains unexplained.
This regression was similar to the model above, except that the normal
distribution on log(observations) was replaced with a multivariate normal
distribution. Thus, in the full model, the observed value Y of response var-
iable v for individual i of species r in experiment j was modeled as
f(Yv,i,r,j ⃒⃒μv,i,r,j , σe) ∼ N2(μv,i,r,j , σe)
μv,i,r,j = X’iβv + qv,r + ov,j ,
where v = 1 represents the incubation period [i.e., Yv=1 = log(T)] and v = 2 is
the virus titer in the salivary glands. Virus titer was thus also modeled as log-
normal, that is, Yv=2 = log(1 +W), where W represents the observed titers,
which may be 0 if no virus was detected in the salivary glands. βv is a vector of
coefficients unique to each response variable, while qv,r and ov,r are random
effects for inoculated species phylogeny and experiment, respectively.
In these models, σ« is a variance-covariance matrix of the form
σ« = [ σ2«,v=1 σ«,v=1,v=2
σ«,v=1,v=2 σ2«,v=2
],
where σ2«,v=1 is the residual variance in response variable 1 (incubation period
durations) and σ«,v=1,v=2 is the residual covariance between incubation pe-
riod durations and salivary gland titers. From this, the Pearson correlation
between incubation periods and salivary gland titers can be calculated as
σ«,v=1,v=2
σ2«,v=1 · σ2«,v=2
.
Explanatory Variables. Variables measuring differences between the reservoir
and the inoculated species were included to assess the influence of previous
virus adaptation on the outcome of infection in heterologous host species.
These included the phylogenetic distance between the reservoir and the
inoculated species, measured as patristic distances along the same composite
time-scaled phylogeny generated by timetree.org used above. As above,
similar results were obtained when using the mammalian supertree of ref.
43. We also included the difference in typical body temperatures between the
reservoir and inoculated species, as an example of a physiological difference
which does not appear to follow phylogenetic constraints (25), because tem-
perature is known to affect rabies virus infectivity in vitro (29). Finally, a binary
variable distinguishing viruses derived from bat and carnivore reservoirs was
included, because differences in the clinical presentation of bat- and carnivore-
associated rabies virus infection in humans have been noted (22).
Features of the inoculated host species where accommodated primarily
through random effects for species and inoculated species phylogeny.
However, we also included a measure of the typical body mass of the in-
oculated species, since larger species may be proportionally more resistant to
the effects of a given dose of virus. Because only some species maintain rabies
virus transmission endemically, for reasons that are not well understood, a
binary variable distinguishing known reservoirs of rabies virus from other
inoculated species was also included.
Differences between experiments were accommodated by including
variables for dose, the inoculation site, and whether the inoculum consisted
of brain material or was derived from salivary glands/saliva, along with a
random effect distinguishing between experiments to accommodate any
remaining differences. Because the doses encountered in these experiments
differed over several orders ofmagnitude and the effects of increasing dose is
assumed to decrease (saturate) at very large doses, this variable was included
in its log-transformed form. The varying inoculation sites encountered were
summarized as a “proportional inoculation distance,” representing the rel-
ative distance between the inoculation site and the brain (the primary site of
rabies virus replication). This distance was calculated by classifying inocula-
tion sites by body part (head, neck, torso, or limbs) and depth (intracranial,
intramuscular, or subcutaneous) and was expressed as a proportion, where 1
indicates the furthest and shallowest possible inoculation site relative to the
brain (subcutaneous inoculation of a limb), while 0 indicates intracerebral
inoculation (SI Appendix, Table S3). Such proportional scaling means this
variable is independent of the differing body sizes of the inoculated species,
which allowed us to account for inoculation site and inoculated species body
size in the same model. This, in turn, allowed us to include an interaction
term between dose and the typical body mass of each inoculated species, to
capture potential differences in dose–response between species of different
sizes. Including a similar interaction between our inoculation distance
measure and body mass caused identifiability issues, with the model unable
to distinguish between the main effect of inoculation distance and the ef-
fect of this interaction. We therefore concluded that such an interaction was
not needed here. Finally, because larger doses may compensate for any
decreases in infectivity caused by features of the inoculated species and/or
physiological differences between the inoculated species and the reservoir
to which the virus was adapted, we also included interactions between dose
and all other host and virus effects above.
Model Fitting.Models were fit using version 2.25 of the MCMCglmm package
in R version 3.5.1 (44, 45). All coefficients and the residual variance param-
eter received the default prior distributions used by MCMCglmm, while
parameter-expanded priors were used for the variance parameters of all
random effects (46). For the incubation and clinical period duration datasets,
models were fitted using 5 million MCMC steps, saving every 500th sample.
Joint incubation period duration–salivary gland titer models were fitted
using 1 million MCMC steps, saving every 100th sample. The first 10% of
samples in each chain were discarded as burn-in. Results were inspected and
summarized using version 0.18-1 of the coda package in R (47). Effective
sample sizes were checked to ensure efficient sampling was achieved, and
chains were visually inspected for convergence.
Data Availability. Raw data and all data processing and analysis code have
been deposited in Zenodo (https://doi.org/10.5281/zenodo.3746609).
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